Repligen Corporation
RGEN
$147.06
$6.054.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.93% | 14.83% | 18.12% | 21.91% | 14.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.93% | 14.83% | 18.12% | 21.91% | 14.81% |
| Cost of Revenue | 5.28% | 10.50% | 7.85% | 16.33% | 16.37% |
| Gross Profit | 18.33% | 18.51% | 29.28% | 27.28% | 13.35% |
| SG&A Expenses | 8.06% | 8.25% | 23.28% | 30.28% | 17.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.24% | 10.18% | 14.02% | 23.90% | 18.22% |
| Operating Income | 134.04% | 102.20% | 96.63% | -0.34% | -29.04% |
| Income Before Tax | -22.30% | -77.69% | 149.51% | 1,589.30% | 101.78% |
| Income Tax Expenses | 173.07% | -410.51% | 222.94% | 544.65% | 1.06% |
| Earnings from Continuing Operations | -66.31% | 42.93% | 139.23% | 2,379.97% | 160.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.31% | 42.93% | 139.23% | 2,379.97% | 160.21% |
| EBIT | 134.04% | 102.20% | 96.63% | -0.34% | -29.04% |
| EBITDA | 34.98% | 35.95% | 36.05% | 8.44% | -0.76% |
| EPS Basic | -66.41% | 42.35% | 139.06% | 2,364.96% | 158.71% |
| Normalized Basic EPS | 52.89% | 69.66% | 182.23% | -32.68% | -17.59% |
| EPS Diluted | -65.85% | 47.90% | 137.74% | 2,322.22% | 160.00% |
| Normalized Diluted EPS | 52.98% | 69.89% | 180.49% | -33.01% | -17.16% |
| Average Basic Shares Outstanding | 0.33% | 0.41% | 0.45% | 0.45% | 0.63% |
| Average Diluted Shares Outstanding | 0.23% | 0.19% | 1.07% | 0.93% | 0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |